HORMONE-RESISTANT PROSTATE CANCER
Clinical trials for HORMONE-RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new HORMONE-RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for HORMONE-RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for men with hard-to-treat prostate cancer: adding immunotherapy to existing drug
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab can help men whose advanced prostate cancer has stopped responding to the hormone therapy enzalutamide. About 58 men with castration-resistant prostate cancer that has spread will receive pembrolizumab while con…
Matched conditions: HORMONE-RESISTANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 26, 2026 06:51 UTC
-
Diet before chemo may cut side effects and boost results
Symptom relief OngoingThis study tests whether eating a low-calorie diet before chemotherapy can reduce side effects like fatigue, nausea, and mouth sores, and also improve how well the treatment works. About 130 adults with breast or prostate cancer will be randomly assigned to either follow the spec…
Matched conditions: HORMONE-RESISTANT PROSTATE CANCER
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated May 26, 2026 06:42 UTC
-
Gene hunt in prostate cancer: no cure, just clues
Knowledge-focused OngoingThis study collects tissue, blood, and urine samples from 92 men with prostate cancer that has spread. Researchers look for gene changes that might explain how well the cancer responds to standard hormone therapy. The goal is to find biomarkers, not to test a new treatment.
Matched conditions: HORMONE-RESISTANT PROSTATE CANCER
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 26, 2026 06:48 UTC